BCL6 and lymphoma: Most studies agree in recognizing that patients with DH lymphoma have lower survival than other DLBCL, while results are still controversial on the prognostic role of the isolated MYC translocation or immunohistochemical overexpression alone of MYC, BCL2, and/or BCL6 (DE lymphomas).